Stay updated on Nivolumab vs Sorafenib in Advanced Hepatocellular Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab vs Sorafenib in Advanced Hepatocellular Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab vs Sorafenib in Advanced Hepatocellular Carcinoma Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.1%
    Check dated 2025-04-30T13:51:36.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The page has undergone significant content changes, including the removal of detailed study information regarding the treatment of Advanced Hepatocellular Carcinoma and the revision number update from v2.14.4 to v2.15.0.
    Difference
    5%
    Check dated 2025-04-16T01:41:31.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.14.3 to v2.14.4, and a date has been added for February 17, 2025, while a date for March 25, 2025, has been removed.
    Difference
    0.3%
    Check dated 2025-04-08T20:15:02.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    The page has been updated to reflect the latest version, v2.14.3, and the last update date has been changed to March 25, 2025. The previous version, v2.14.2, and its update date of February 17, 2025, have been removed.
    Difference
    0.2%
    Check dated 2025-04-01T14:57:21.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    The webpage has updated its last update dates to early 2025 and removed older update dates from 2024 and earlier.
    Difference
    2%
    Check dated 2025-03-03T22:13:27.000Z thumbnail image
  8. Check
    88 days ago
    Change Detected
    Summary
    The web page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    1.0%
    Check dated 2025-02-10T09:25:54.000Z thumbnail image

Stay in the know with updates to Nivolumab vs Sorafenib in Advanced Hepatocellular Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab vs Sorafenib in Advanced Hepatocellular Carcinoma Clinical Trial page.